Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
Democratic leaders acknowledge families' shutdown suffering as political leverage to advance healthcare agenda, while Republicans criticize them for prioritizing politics over public welfare.
Discover hidden coastal and island escapes, from private luxury islands to rugged nature-filled shores, across the Pacific, Atlantic, Caribbean, and U.S.
Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
Democratic leaders acknowledge families' shutdown suffering as political leverage to advance healthcare agenda, while Republicans criticize them for prioritizing politics over public welfare.
Discover hidden coastal and island escapes, from private luxury islands to rugged nature-filled shores, across the Pacific, Atlantic, Caribbean, and U.S.